The Involvement of the Apoptosis-Modulating Proteins ERK 1/2, Bcl-xL and Bax in the Resolution of Acute Inflammation in Vivo
- 31 January 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 168 (1), 33-41
- https://doi.org/10.2353/ajpath.2006.050058
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Persistence of apoptotic cells without autoimmune disease or inflammation in CD14−/− miceThe Journal of cell biology, 2004
- Expression of the apoptosis inhibitor Bcl‐2 in sputum eosinophils from children with acute asthmaClinical and Experimental Allergy, 2004
- Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophilsCellular Signalling, 2004
- Inducible cyclooxygenase‐derived 15deoxy Δ12‐14PGJ2brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosisThe FASEB Journal, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Points of control in inflammationNature, 2002
- Flavonoids differentially regulate IFNγ‐induced ICAM‐1 expression in human keratinocytes: molecular mechanisms of actionFEBS Letters, 2002
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.JCI Insight, 1998
- REDUCTION OF THE INCIDENCE OF REJECTION BY ADJUNCT IMMUNOSUPPRESSION WITH PHOTOCHEMOTHERAPY AFTER HEART TRANSPLANTATIONTransplantation, 1994
- Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoidsInflammation Research, 1991